文献速递癫痫

美国老年医保人群癫痫发病率及危险因素

Incidence and Risk Factors of Epilepsy Among Older Adults in the US Medicare Population.
PubMed 文献 · JAMA Neurol · 2026-01-01

该队列研究分析2016至2019年美国本土各县老年医保索赔数据,随机抽样4 999 999名65岁及以上受益人并过采样非西班牙裔黑人和西班牙裔。2019年识别20 263例新发癫痫,MaxCounties发病率差异超过10倍(141-1476/10万),睡眠不足和缺乏家庭车辆与高发病率相关。

要点

  • 2019年老年医保人群新发癫痫20 263例,MaxCounties发病率141-1476/10万。
  • 睡眠不足最高三分位区癫痫高发 odds 近乎翻倍(OR 1.99;95%CI 1.10-3.60)。
  • 缺乏家庭车辆获取与高发病率相关(OR 1.93;95%CI 1.16-3.25)。

核心结论

  • 美国老年医保人群癫痫负担存在空间异质性,睡眠、出行与基础设施等社会与环境决定因素与高发地区相关。

研究设计与样本

  • 队列研究分析2016至2019年美国本土所有县医保行政索赔数据。
  • 随机抽样4 999 999名65岁及以上Fee-for-Service受益人,非西班牙裔黑人和西班牙裔分别按1.50和1.75倍过采样。
  • 最终分析4 817 147名受益人,2019年识别20 263例新发癫痫,平均年龄78.7(SD 7.5)岁,54.6%为女性。

主要发现

  • MaxCounties癫痫发病率差异超过10倍,范围为141-1476/10万。
  • 随机森林模型中,高发病率与睡眠不足、热指数、缺乏体力活动、无保险率、非西班牙裔黑人居民比例和肥胖患病率相关。
  • 多变量回归中,睡眠不足最高三分位区高癫痫发病率的OR为1.99(95%CI 1.10-3.60)。
  • 缺乏家庭车辆获取与高发病率相关,OR为1.93(95%CI 1.16-3.25)。

临床怎么用

  • 可依据地区社会与环境决定因素识别癫痫高发区域,为针对性公共卫生干预和资源分配提供参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Geographic variation in epilepsy incidence among older adults may reflect contextual risk factors and point to opportunities for targeted prevention. However, privacy constraints and sparse case counts have historically limited small-area analyses. OBJECTIVE: To map incident epilepsy among older adults at the smallest geography permissible by privacy constraints and identify contextual social and environmental determinants associated with high-incidence areas. DESIGN, SETTING, AND PARTICIPANTS: This cohort study examined Medicare administrative claims from 2016 to 2019 for all counties in the contiguous United States. A random sample of 4 999 999 Medicare Fee-for-Service beneficiaries 65 years or older with non-Hispanic Black and Hispanic beneficiaries oversampled at rates of 1.50 and 1.75 times their representation in the study population. Beneficiaries with incident epilepsy were identified by claims criteria and codes from the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, in 2019 and had no epilepsy claims during the period 2016 to 2018. Data were analyzed from January to March 2025. EXPOSURES: Area-level social and environmental determinants of health (SEDH), obtained from publicly available sources and linked to beneficiaries' residences. MAIN OUTCOMES AND MEASURES: The outcome was area-level epilepsy incidence rate in 2019. To comply with data privacy requirements, the Max-P regionalization method was used to aggregate 3108 counties into 692 "MaxCounties," each containing at least 11 incident cases. Incidence rates per 100 000 persons were mapped. Associations between SEDH variables and epilepsy incidence were estimated using random forest and multivariable logistic regression. RESULTS: Among 4 817 147 beneficiaries, 20 263 incident epilepsy cases were identified in 2019 (mean [SD] age, 78.7 [7.5] years; 54.6% women). Incidence rates across MaxCounties varied more than 10-fold (range, 141-1476 per 100 000). In random forest models, higher incidence was associated with insufficient sleep, heat index, physical inactivity, uninsured rate, proportion of non-Hispanic Black residents, and obesity prevalence. In multivariable regression, MaxCounties in the highest tertile for insufficient sleep had nearly double the odds of high epilepsy incidence compared to the lowest tertile (odds ratio [OR], 1.99; 95% CI, 1.10-3.60). Lack of household vehicle access was similarly associated with high incidence (OR, 1.93; 95% CI, 1.16-3.25). CONCLUSIONS AND RELEVANCE: Our findings highlight the spatial heterogeneity of epilepsy burden in the US Medicare population and underscore the importance of contextual SEDH factors, such as sleep, mobility, and infrastructure, in shaping disease patterns. These insights may help guide targeted public health interventions and resource allocation.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Dong W, Cabulong A, Vu L, et al. Incidence and Risk Factors of Epilepsy Among Older Adults in the US Medicare Population. JAMA Neurol. 2026. PMID: 41212547. doi:10.1001/jamaneurol.2025.4347

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。